The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies.

Cancer Biol Ther · 2024 · PMC10962586 · PMID 38521968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

However, there was a slight trend for decreased phospho-AKT (pAKT) and pS6 levels in response to BRAF and MEK1/2 inhibition in sensitive cell lines (BCPAP, SW1736), but not in resistant cells (T238, TCO1) (Supplementary Figure S3).

also in 2,042 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.